A Long-Term Study of Navenibart in Participants With Hereditary Angioedema

Clinical trial NCT07204938 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07204938
Sponsor: Astria Therapeutics, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2025-10-01
Primary completion: 2031-06-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.